IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $687,465 | -32.5% | 151,091 | +4.5% | 0.00% | – |
Q2 2023 | $1,018,252 | +17.2% | 144,638 | +1.7% | 0.00% | – |
Q1 2023 | $868,774 | +40.4% | 142,189 | +46.9% | 0.00% | – |
Q4 2022 | $618,642 | -33.6% | 96,814 | -0.4% | 0.00% | – |
Q3 2022 | $931,000 | -94.9% | 97,178 | -94.1% | 0.00% | -100.0% |
Q2 2022 | $18,087,000 | -34.6% | 1,638,255 | -1.4% | 0.01% | -28.6% |
Q1 2022 | $27,661,000 | -8.7% | 1,661,292 | +4.7% | 0.01% | 0.0% |
Q4 2021 | $30,297,000 | +19.7% | 1,587,067 | +54.6% | 0.01% | +16.7% |
Q3 2021 | $25,317,000 | -5.9% | 1,026,657 | -0.7% | 0.01% | -14.3% |
Q2 2021 | $26,915,000 | -27.2% | 1,034,365 | -11.4% | 0.01% | -30.0% |
Q1 2021 | $36,975,000 | -50.4% | 1,167,872 | -27.2% | 0.01% | -54.5% |
Q4 2020 | $74,484,000 | +43.4% | 1,605,263 | +1.7% | 0.02% | +22.2% |
Q3 2020 | $51,942,000 | +54.5% | 1,577,816 | +28.8% | 0.02% | +50.0% |
Q2 2020 | $33,622,000 | +511.1% | 1,224,821 | +566.3% | 0.01% | +500.0% |
Q1 2020 | $5,502,000 | +71.5% | 183,826 | +58.6% | 0.00% | +100.0% |
Q4 2019 | $3,209,000 | -2.0% | 115,931 | -13.2% | 0.00% | 0.0% |
Q2 2019 | $3,276,000 | -18.8% | 133,591 | -57.6% | 0.00% | 0.0% |
Q2 2018 | $4,036,000 | – | 315,330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |